ArticleComputational and structural biotechnology journal2025
Leveraging MDS2 and SBOM data for LLM-assisted vulnerability analysis of medical devices.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ethical issues in multi-agent AI systems for healthcare: a narrative review.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the use of a semi-automated, Retrieval-Augmented Generation (RAG)-based multi-agent architecture to analyze security-relevant data and assemble specialized exploitation paths targeting medical devices. The input dataset comprised device-specific sources, namely, the Manufacturer Disclosure Statement for Medical Device Security (MDS2) documents and Software Bills of Materials (SBOMs), enriched with public vulnerability databases, including Common Vulnerabilities and Exposures (CVE), Known Exploited Vulnerabilities (KEV), and Metasploit exploit records. The objective was to assess whether a modular, Large Language Model (LLM)-driven agent system could autonomously correlate device metadata with known vulnerabilities and existing exploit information to support structured threat modeling. The architecture follows a static RAG design based on predefined prompts and fixed retrieval logic, without autonomous agent planning or dynamic query adaptation. The developed Vulnerability Intelligence for Threat Analysis in Medical Security (VITAMedSec) system operates under human-prompted supervision and successfully synthesizes actionable insights and exploitation paths without requiring manual step-by-step input during execution. Although technically coherent results were obtained under controlled conditions, real-world validation remains a critical avenue for future research. This study further discusses the dual-use implications of such an agent-based framework, its relevance to patient safety in medical device cybersecurity, and the broader applicability of the proposed architecture to other critical infrastructure sectors. These findings emphasize both the technical potential and ethical responsibility for applying semi-automated AI workflows in medical cybersecurity contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.